在无标准可改变危险因素的急性心肌梗死中，肝脂肪变性和重度纤维化是死亡率的独立预测因素。 - Suppr | 超能文献

相似文献

1

Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors.在无标准可改变危险因素的急性心肌梗死中，肝脂肪变性和重度纤维化是死亡率的独立预测因素。

Diabetes Obes Metab. 2022 Dec;24(12):2454-2458. doi: 10.1111/dom.14820. Epub 2022 Aug 1.

2

Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction.肝脂肪变性和晚期肝纤维化是急性心肌梗死长期死亡率的独立预测因素。

Diabetes Obes Metab. 2023 Apr;25(4):1032-1044. doi: 10.1111/dom.14950. Epub 2023 Jan 6.

3

Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B.脂肪肝与晚期纤维化相关，但不能预测慢性乙型肝炎患者的不良结局。

J Viral Hepat. 2020 Dec;27(12):1297-1305. doi: 10.1111/jvh.13361. Epub 2020 Aug 27.

4

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.采用脂肪肝指数和 BARD 评分评估肝脂肪变性和纤维化与新发 2 型糖尿病患者心血管结局和死亡率的关系：一项全国性队列研究。

Cardiovasc Diabetol. 2022 Apr 16;21(1):53. doi: 10.1186/s12933-022-01483-y.

5

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.基因3型慢性丙型肝炎和非酒精性脂肪性肝病中的纤维化：胰岛素抵抗和肝脂肪变性的作用

Hepatology. 2006 Dec;44(6):1648-55. doi: 10.1002/hep.21429.

6

Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.未经治疗的慢性乙型肝炎青年男性的肝脂肪变性和肝纤维化

Liver Int. 2009 Jul;29(6):878-83. doi: 10.1111/j.1478-3231.2009.01976.x. Epub 2009 Jan 22.

7

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.慢性丙型肝炎中的纤维化与体重指数和脂肪变性显著相关。

Hepatology. 1999 Apr;29(4):1215-9. doi: 10.1002/hep.510290401.

8

Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.肥胖和脂肪肝是肝纤维化机制的“润滑剂”。

Dig Dis. 2011;29(4):377-83. doi: 10.1159/000329800. Epub 2011 Aug 30.

9

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.2 型糖尿病患者肝脂肪变性和非酒精性脂肪性肝病的患病率及相关危险因素：爱丁堡 2 型糖尿病研究。

Diabetes Care. 2011 May;34(5):1139-44. doi: 10.2337/dc10-2229. Epub 2011 Apr 8.

10

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.慢性乙型和丙型肝炎中的肝脂肪变性：预测因素、分布及其对纤维化的影响。

J Hepatol. 2005 Jul;43(1):38-44. doi: 10.1016/j.jhep.2005.01.031. Epub 2005 Apr 8.

引用本文的文献

1

Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.胰高血糖素样肽-1受体激动剂在心肌梗死及降低动脉粥样硬化性心血管疾病风险中的应用：治疗所需人数、疗效及安全性的综合荟萃分析

Cardiovasc Diabetol. 2025 Jul 12;24(1):285. doi: 10.1186/s12933-025-02840-3.

2

A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction.成年急性心肌梗死患者中瘦型2型糖尿病预后价值的性别分层分析

Cardiovasc Diabetol. 2025 Feb 7;24(1):59. doi: 10.1186/s12933-024-02552-0.

3